C12N2730/10021

RNAI AGENT FOR INHIBITING HBV EXPRESSION AND USE THEREOF
20240124879 · 2024-04-18 ·

The present application relates to an RNA interference (RNAi) agent for inhibiting the expression of hepatitis B virus and uses thereof, and to an RNAi agent that inhibits the expression of hepatitis B virus and a pharmaceutical composition including the RNAi agent for amelioration or treatment of diseases caused by hepatitis B virus infection.